ArticleResearch square2026
Repeated influenza vaccination results in blunting rather than back-boosting of antibody responses against A(H3N2) antigens.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
Hemagglutination inhibiting (HI) antibody responses against influenza A(H3N2) vaccine strains decline with increasing years of vaccination. It is hypothesized that memory B cell dominance may direct antibody responses towards epitopes conserved with previously-encountered vaccine strains, including non-HI epitopes. To investigate this, we compared healthcare workers with zero versus five consecutive years of vaccination prior to enrolment in 2020 or 2021. We evaluated HI antibody reactivity across 25 A(H3N2) viruses spanning 2007-2022 and antibody binding to recombinant hemagglutinins (HA). HI antibody responses were poor across strains for participants vaccinated five compared to zero of five prior years, independent of pre-vaccination titre. HA and HA-stem binding antibody titre-rises were likewise attenuated in the repeatedly vaccinated group. These results provide no evidence that repeated vaccination promotes antibodies targeting conserved epitopes, rather, repeated vaccination broadly attenuates antibody responses. Work is ongoing to investigate whether attenuation reflects deficient memory B cell differentiation into plasmablasts.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.